Hainan Huluwa Pharmaceutical Group Co., Ltd.

¥5.36As of Sun 8 Nov 2026, 12:00 UTC
SSE:605199Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (24.25%)
Div yield —
ROE (80.02%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.42
PE TTM —
TSR TTM (41.74%)
Mkt cap ¥2.145B
ROIC (30.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.35
18.53%
(63.67%)
Hold 0|0|4|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.08
0.08
(7.67%)
(6.60%)
2.01%
5.82%
Revenue¥M
113.9
112.5
111.6
115.9
11.22%
6.91%
0.08%
3.49%
Peers (US$321.5M)
Cap (US$)
PE
321.2M
—
Capital
TTM
5Y
10Y
Leveragex
2.010
(0.021)
(0.015)
EBIT/Intx
0.854
0.215
0.190
Own earn%
43.74
147.86
140.48
Sh yield%
49.59
40.75
40.57
Owners
Insiders/Inst%
10.20
34.04
Short interest%
5.19
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
22–25
$1 testx
—
Incr. ROIC%
21